UnknownPHASE2, PHASE3NCT01087398
Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis
Studying Albers-Schönberg osteopetrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tehran University of Medical Sciences
- Principal Investigator
- Amir Ali Hamidieh, MD, MDHematology-Oncology and SCT Research Center
- Intervention
- Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2009 – 2012
Study locations (1)
- Hematology-Oncology & SCT Research Center, Tehran, Tehran Province, Iran
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01087398 on ClinicalTrials.gov